Search the Newsreel

Nexmetals Mining Corp. Warrant 2025-17.11.2027 on Nexmetals mng

This page provides financial information for Nexmetals Mining Corp. Warrant 2025-17.11.2027 (TSXV:NEXM.WT), focusing on its enterprise value to revenue forward. It indicates that the market was closed with no trades recorded at the time of publication. The data is sourced from ICE Data Services …

Modi Naturals Publishes Q1 FY2026 Unaudited Results in Newspapers

SpaceX to launch Globalstar mission from Florida's Space Coast

SpaceX is set to launch the Globalstar 2-R Launch 1 mission from Cape Canaveral Space Force Station on Saturday night. The Falcon 9 rocket's first stage booster will be on its 14th flight and is expected to land back at Cape Canaveral. A backup …

TMC The Metals (TMC) Has Investors Watching, What Is Behind The Fresh Attention?

TMC The Metals (TMC) is gaining investor attention due to progress on U.S. seabed mining permits and advancements in its offshore collection system. Despite a recent 7-day share price return of 7.04%, the year-to-date performance shows a decline of 34.96%. The company's fair value …

ANI Pharmaceuticals (ANIP) Could Be 34% Undervalued As Earnings And Guidance Hold

ANI Pharmaceuticals (ANIP) is currently in focus after reporting its Q2 and H1 2026 results and reaffirming its full-year net revenue outlook of $1,080 million to $1,140 million. Despite recent strong earnings, the stock has seen a short-term decline, though it shows significant long-term …

Black Stone Minerals (BSM) Could Be 10% Below Fair Value After Revenue Beat

Black Stone Minerals (BSM) is considered undervalued after exceeding second-quarter revenue expectations due to steady oil volumes and favorable pricing, resulting in a higher cash distribution. Analysts suggest a fair value of $16, indicating a 10.1% undervaluation from its current $14.38 share price, largely …

Anax Metals Ltd - ARM - Stock Price & News

Ionis Pharmaceuticals (IONS) Has A $92 Fair Value Narrative, Is The Stock A Bargain?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals (IONS) has drawn investor attention after recent share price moves, with the stock up over the past month but down over the past …

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks

Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same sector. Today we are looking at …

Top Andean Precious Metals (APM) Competitors 2026

Applied Materials Stock Fell 5% After a Record Q3 2026 Quarter. Here’s Where the Stock Could Go

Niraj Cement Structurals Q1FY26 revenue rises 12% to ₹22.25 crore

Eton Pharmaceuticals Stock Soars After Huge Q2 Beat And Target Hikes

Eton Pharmaceuticals (ETON) stock surged by 45.78% after reporting a significant Q2 beat, with non-GAAP EPS of $0.43 and revenue of $37.6M, driven by 99% year-over-year growth. The company also raised its 2026 revenue guidance to over $145M and adjusted EBITDA margin to at …

Applied Materials Beat Everything but Wall Street’s Expectations for Margins

Eton Pharmaceuticals Soars After Blowout Q2 And Guidance Hike

Eton Pharmaceuticals (NASDAQ: ETON) experienced a significant stock surge of over 45% after reporting blowout Q2 earnings and raising its 2026 revenue guidance. The company's Q2 non-GAAP EPS and revenue significantly beat consensus estimates, driven by strong growth and the successful relaunch of Hemangeol. …

Neo Performance's Record Quarter Sparks a Two-Speed Market Reaction

Applied Materials Beat Every Number and Wall Street Sold the Stock Anyway

Will Aurinia’s Reaffirmed 2026 Guidance and Large Buyback Reshape Aurinia Pharmaceuticals' (AUPH) Narrative?

How Zacks’ Earnings Upgrade At Air Products (APD) Has Changed Its Investment Story

MP Materials: Washington's Supply-Chain Push Collides With a 75% Volatility Problem

Acumen Pharmaceuticals Inc (ABOS) Stock News Today

Don't Ignore The Insider Selling In Rocket Pharmaceuticals

A Chief Operating Officer at Rocket Pharmaceuticals recently sold US$128k worth of shares, representing 6.8% of their holding. This sale was the largest insider sale in the past year, though it occurred around the current market price, making it less concerning than sales at …

Have Triple Flag Precious Metals Insiders Been Selling Stock?

Triple Flag Precious Metals Corp. (TSE:TFPM) has seen significant insider selling recently, including CA$1.1m from the COO and a CA$4.5m sale by an Independent Director. While these sales occurred around the current share price, suggesting less concern than sales at lower prices, the overall …

Die Applied-Materials-Aktie korrigiert nach Rekordquartal und hoher AI-Erwartung

Recursion Pharmaceuticals (RXRX) Stock Dropped, So What Is Behind The Move?

Xenon Pharmaceuticals Independent Director Steven Gannon Sells 84% Of Holding

Walleye Capital LLC Buys Shares of 4,935 CSW Industrials, Inc. $CSW

Walleye Capital LLC initiated a new position in CSW Industrials, Inc. (NYSE:CSW) by purchasing 4,935 shares valued at approximately $1.37 million during the second quarter. Institutional investors collectively own 82.79% of the company, while recent analyst reports indicate a "Moderate Buy" consensus with an …

Summit Global Investments Acquires Shares of 7,182 Vertex Pharmaceuticals Incorporated $VRTX

Summit Global Investments purchased 7,182 shares of Vertex Pharmaceuticals (NASDAQ:VRTX) in the second quarter, valued at approximately $3.57 million. Other hedge funds also adjusted their holdings, with institutional investors now owning 90.96% of the stock. Analysts currently have a "Moderate Buy" rating for VRTX …

7,506 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Summit Global Investments

Summit Global Investments acquired 7,506 shares of Regeneron Pharmaceuticals (NASDAQ:REGN) valued at $4.68 million during the second quarter. Regeneron reported strong quarterly results, beating analyst estimates with $14.29 EPS and $4.29 billion in revenue, representing a 16.7% year-over-year increase. Despite a "Moderate Buy" consensus …

Rhythm Pharmaceuticals(RYTM.US) Officer Sells US$8.9 Million in Common Stock

An officer at Rhythm Pharmaceuticals (RYTM.US) recently sold a substantial amount of common stock, totaling US$8.9 million. This transaction indicates a significant insider sale for the company.

268,144 Shares in Wheaton Precious Metals Corp. $WPM Acquired by Stack Financial Management Inc

Walleye Capital LLC Buys Shares of 106,112 ANI Pharmaceuticals, Inc. $ANIP

Walleye Capital LLC has acquired a new position in ANI Pharmaceuticals, purchasing 106,112 shares valued at approximately $8.8 million, indicating growing institutional interest as hedge funds and other investors collectively own 76.05% of the company. ANI Pharmaceuticals recently surpassed quarterly earnings expectations, reporting adjusted …

Trifecta Capital Advisors LLC Purchases New Position in Vertex Pharmaceuticals Incorporated $VRTX

Trifecta Capital Advisors LLC has acquired a new position in Vertex Pharmaceuticals (NASDAQ:VRTX), purchasing 16,745 shares valued at approximately $8.318 million, making it their 27th largest holding. Other institutional investors like Capital Research Global Investors and State Street Corp also increased their stakes. This …

Oppenheimer Asset Management Inc. Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX

Oppenheimer Asset Management Inc. has acquired a new stake of 17,931 shares in Vertex Pharmaceuticals (NASDAQ:VRTX), valued at approximately $8.91 million during the second quarter. This new investment comes as other institutional investors have also adjusted their holdings in VRTX. Vertex Pharmaceuticals reported earnings …

Rayonier (RYAM) Q2 2026 Earnings Call Transcript

86,249 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Walleye Capital LLC

Walleye Capital LLC has acquired 86,249 shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) during the second quarter, valued at approximately $3.12 million, representing a 0.31% stake in the company. This acquisition comes as Eton Pharmaceuticals reported strong quarterly results, exceeding revenue and EPS expectations, and …